These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 20272343)

  • 1. The estimation of specific antigen in strains of Hemophilus pertussis.
    SMOLENS J; McLAREN CS
    J Immunol; 1947 Dec; 57(4):361-7. PubMed ID: 20272343
    [No Abstract]   [Full Text] [Related]  

  • 2. The separation of a protective antigen from a toxin-producing strain of Hemophilus pertussis.
    ROBBINS KC; PILLEMER L
    J Immunol; 1950 Oct; 65(4):393-406. PubMed ID: 14794902
    [No Abstract]   [Full Text] [Related]  

  • 3. Adsorption of protective antigen of Hemophilus pertussis on human red cell stromata.
    PILLEMER L
    Proc Soc Exp Biol Med; 1950 Dec; 75(3):704-5. PubMed ID: 14808372
    [No Abstract]   [Full Text] [Related]  

  • 4. [Antigenic structure of the English national and American strains of phase I Hemophilus pertussis].
    MARGNI RA
    Prensa Med Argent; 1956 Mar; 43(9):764-5. PubMed ID: 13350008
    [No Abstract]   [Full Text] [Related]  

  • 5. [Role of methods of handling and of structure of strains in nature of toxic substances obtained from Hemophilus pertussis].
    PALANT BL; FINTIKTIKOVA RP; MITEL'MAN PM
    Zh Mikrobiol Epidemiol Immunobiol; 1955 Sep; (9):34-7. PubMed ID: 13282450
    [No Abstract]   [Full Text] [Related]  

  • 6. [Effects of crude toxin of Hemophilus pertussis and anti-crude toxin sera on infection with Hemophilus pertussis. I. Effects of pretreatment with crude toxin of Hemophilus pertussis and its anti-crude toxin sera on pulmonary infection with Hemophilus pertussis].
    KOBAYASHI K
    Paediatr Jpn; 1961; 65():293-300. PubMed ID: 13757276
    [No Abstract]   [Full Text] [Related]  

  • 7. [Effects of crude toxin of Hemophilus pertussis and anti-crude toxin sera on infection with Hemophilus pertussis. II. Effects of repeated pretreatments with crude toxin of Hemophilus pertussis and effects of anti-vaccine sera and the anti-crude sera on infection with Hemophilus pertussis].
    KOBAYASHI K
    Paediatr Jpn; 1961; 65():301-8. PubMed ID: 13757277
    [No Abstract]   [Full Text] [Related]  

  • 8. Hemophilus pertussis soluble antigen and complement fixing antibodies.
    PARFENTJEV IA; VIRION ME
    J Immunol; 1948 Sep; 60(1):167-71. PubMed ID: 18881078
    [No Abstract]   [Full Text] [Related]  

  • 9. A soluble antigen of phase 1 Hemophilus pertussis. I. Mouse protection test of filtrate or supernatant of cultures in a medium without soluble starch or carbon particles.
    KUWAJIMA Y; MASUI M; ASANO A; MATSUI T
    J Immunol; 1956 Mar; 76(3):175-80. PubMed ID: 13306951
    [No Abstract]   [Full Text] [Related]  

  • 10. [The agglutinogen function of Hemophilus pertussis].
    PASCHOUD JM
    Schweiz Z Pathol Bakteriol; 1952; 15(4):454-7. PubMed ID: 13015080
    [No Abstract]   [Full Text] [Related]  

  • 11. Preparation of an antigen mixture from H. pertussis by selective denaturation.
    HINK JH; JOHNSON FF
    J Immunol; 1947 Dec; 57(4):323-30. PubMed ID: 20272339
    [No Abstract]   [Full Text] [Related]  

  • 12. Protective antigen of haemophilus pertussis.
    PILLEMER L; BLUM L; LEPOW IH
    Lancet; 1954 Jun; 266(6825):1257-60. PubMed ID: 13164367
    [No Abstract]   [Full Text] [Related]  

  • 13. THE CONTENT OF ANTIGENS 1,2 AND 3 IN STRAINS OF BORDETELLA PERTUSSIS AND IN VACCINES.
    CHALVARDJIAN N
    Can Med Assoc J; 1965 May; 92(21):1114-6. PubMed ID: 14285295
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Studies on antigens produced from Hemophilus pertussis by modified White-Westphal method].
    BAEVA EA
    Zh Mikrobiol Epidemiol Immunobiol; 1957 Dec; 28(12):71-4. PubMed ID: 13544572
    [No Abstract]   [Full Text] [Related]  

  • 15. Studies on the K antigen of H pertussis; its existence and a method of detection.
    SHIMOJO H; ISHII T
    Jpn J Exp Med; 1954 Apr; 24(2):51-7. PubMed ID: 13221349
    [No Abstract]   [Full Text] [Related]  

  • 16. [Experience in diffusion analysis of antigens and antibodies. III. Study of hemophilus pertussis antigens].
    CHISTOVICH GN
    Zh Mikrobiol Epidemiol Immunobiol; 1956 Apr; 27(4):17-22. PubMed ID: 13338794
    [No Abstract]   [Full Text] [Related]  

  • 17. [Studies of the reaction of the living body to pertussis vaccine, with special reference to electromyographic experiments with the intercostal muscles. II. Electromyogram of the intercostal muscles by inoculation with Hemophilus pertussis type I and Hemophilus pertussis toxin after Hemophilus pertussis vaccination].
    KURODA I
    Paediatr Jpn; 1961 Jun; 65():643-8. PubMed ID: 13755302
    [No Abstract]   [Full Text] [Related]  

  • 18. The haemagglutinin of Haemophilus pertussis. III. Extraction of the antigen from the bacteria and its stabilization by adsorption.
    WARBURTON MF; FISHER S
    Aust J Exp Biol Med Sci; 1951 Jul; 29(4):265-72. PubMed ID: 14886263
    [No Abstract]   [Full Text] [Related]  

  • 19. Antigenic Hemophilus pertussis vaccines grown on charcoal agar.
    ENSMINGER PW; CULBERTSON CG; POWELL HM
    J Infect Dis; 1953; 93(3):266-8. PubMed ID: 13109242
    [No Abstract]   [Full Text] [Related]  

  • 20. [Antigenic and immunogenic qualities of various phases of Hemophilus pertussis].
    MAMAEVA EA
    Zh Mikrobiol Epidemiol Immunobiol; 1956 Apr; 27(4):13-7. PubMed ID: 13338793
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.